Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 91, Issue 3, Pages 363-370Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2010.12.027
Keywords
Oral antidiabetic; Health related quality of life; Treatment satisfaction; Diabetes mellitus
Categories
Funding
- Consumer Health Sciences/KantarHealth, Princeton, NJ
Ask authors/readers for more resources
Aims: To quantify patient-reported rates of hypoglycemia and its association with health-related quality of life (HRQL), treatment satisfaction, and healthcare resource utilization. Methods: Data were collected from 2006 to 2008 US National Health and Wellness Survey and the Ailment Panel of Lightspeed Online Research, an internet-based questionnaire. Adults (>= 18 years) with type 2 diabetes taking >= 1 oral antidiabetic agent (OAD), but not insulin, were included (n = 2074). Multivariate analyses included logistic regression and generalized linear models. Results: Overall, patients who reported experiencing hypoglycemia symptoms (n = 286; 13.78%) were significantly more likely to have a lower HRQL on several parameters including: increased limitations on mobility (b = 0.66, OR = 1.93, p < 0.0001) and usual activities (b = 0.58, OR = 1.78, p < 0.0001), increased pain/discomfort (b = 0.69, OR = 2.00, p < 0.0001) and anxiety/depression (b = 0.84, OR = 2.31, p < 0.0001). They also had a lower total treatment satisfaction score as measured by the DiabMedSat tool (b = -7.66, p < 0.0001). Self-reported rates of diabetes-related emergency room (b = 0.98, p = 0.004) and physician visits (b = 0.30, p < 0.0001) were also higher among these patients. Conclusion: Among OAD-treated type 2 diabetes patients, symptoms of hypoglycemia tend to be correlated with significantly lower HRQL, lower treatment satisfaction and higher levels of healthcare resource utilization. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available